534356 Sigma-AldrichPRMT5 Inhibitor, CMP5
Selectively blocks EBV-mediated B lymphocyte transformation & induces lymphoma cell death.
More>> Selectively blocks EBV-mediated B lymphocyte transformation & induces lymphoma cell death. Less<<Synonyms: 1-(9-Ethyl-9H-carbazol-3-yl)-N-(2-pyridinylmethyl)methanamine, 2HCl, 1-(9-Ethyl-9H-carbazol-3-yl)-N-(pyridin-2-ylmethyl)methanamine, 2HCl
Overview
| Replacement Information |
|---|
Key Spec Table
| Empirical Formula |
|---|
| C₂₁H₂₁N₃•2HCl |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.34356.0001 |
|
Glass bottle | 10 mg |
|
— |
| References | |
|---|---|
| References | Alinari, L., et al. 2015. Blood. 125, 2530. |
| Product Information | |
|---|---|
| Form | Yellow solid |
| Formulation | Supplied as HCl salt. |
| Hill Formula | C₂₁H₂₁N₃•2HCl |
| Chemical formula | C₂₁H₂₁N₃•2HCl |
| Hygroscopic | Hygroscopic |
| Reversible | Y |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | PRMT5 |
| Purity | ≥98% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas |
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 5.34356.0001 | 04054839117152 |
Documentation
PRMT5 Inhibitor, CMP5 SDS
| Title |
|---|
References
| Reference overview |
|---|
| Alinari, L., et al. 2015. Blood. 125, 2530. |



